Literature DB >> 12949385

Diallyl disulfide induces ERK phosphorylation and alters gene expression profiles in human colon tumor cells.

L M Knowles1, J A Milner.   

Abstract

Diallyl disulfide (DADS), a compound found in processed garlic, has been shown to arrest unsynchronized human colon tumor cells (HCT-15) in the G(2)/M phase of the cell cycle. The present studies were designed to examine whether this cell cycle block related to alterations in protein kinase C (PKC), Ca(2+)/calmodulin-dependent protein kinase II (CAMK II) or extracellular signal-regulated kinase (ERK) activity. Exposing double thymidine synchronized HCT-15 cells to DADS (25, 50 and 100 micromol/L) for 4 h increased the G(2)/M population by 30, 31 and 63%, respectively, compared with controls (P < 0.05). PKC and CAM KII activities were not influenced by increasing DADS exposure and thus did not correlate with the block of cells in the G(2)/M phase. Although ERK activity increased by 44 and 60% after treatment with 100 and 500 micromol/L DADS (P < 0.05), it was not influenced by exposure to 25 or 50 micromol/L DADS. Western blot analysis revealed that although DADS (25, 50, 100 and 500 micromol/L) did not influence the quantity of ERK protein expressed, it did increase its phosphorylation by 39, 52, 73 and 61%, respectively, compared with controls (P < 0.05). These studies provide evidence that early alterations in ERK pathway signaling may contribute to the G(2)/M arrest observed after DADS exposure. Preliminary data generated using the Clonetech Atlas Human Cancer cDNA Expression Array suggest that alterations in cell cycle, DNA repair and cellular adhesion factors accompany DADS exposure and may also be involved in mediating the block in G(2)/M progression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12949385     DOI: 10.1093/jn/133.9.2901

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  7 in total

1.  Antileukemic activity of sulfoxide nutraceutical allicin against THP-1 cells is associated with premature phosphatidylserine exposure in human erythrocytes.

Authors:  Samar A Sultan; Mohammed H Khawaji; Jawaher Alsughayyir; Mohammad A Alfhili; Hassan S Alamri; Bahauddeen M Alrfaei
Journal:  Saudi J Biol Sci       Date:  2020-09-08       Impact factor: 4.219

2.  Upregulation of miR-34a by diallyl disulfide suppresses invasion and induces apoptosis in SGC-7901 cells through inhibition of the PI3K/Akt signaling pathway.

Authors:  Guojun Wang; Guanghui Liu; Yanwei Ye; Yang Fu; Xiefu Zhang
Journal:  Oncol Lett       Date:  2016-02-24       Impact factor: 2.967

3.  Allicin alleviates inflammation of trinitrobenzenesulfonic acid-induced rats and suppresses P38 and JNK pathways in Caco-2 cells.

Authors:  Chen Li; Weijian Lun; Xinmei Zhao; Shan Lei; Yandong Guo; Jiayi Ma; Fachao Zhi
Journal:  Mediators Inflamm       Date:  2015-02-02       Impact factor: 4.711

Review 4.  The role of nutrition related genes and nutrigenetics in understanding the pathogenesis of cancer.

Authors:  Ayman Zaky Elsamanoudy; Moustafa Ahmed Mohamed Neamat-Allah; Fatma Azzahra' Hisham Mohammad; Mohammed Hassanien; Hoda Ahmed Nada
Journal:  J Microsc Ultrastruct       Date:  2016-03-08

Review 5.  Bioactive Nutrients and Nutrigenomics in Age-Related Diseases.

Authors:  Tania Rescigno; Luigina Micolucci; Mario F Tecce; Anna Capasso
Journal:  Molecules       Date:  2017-01-08       Impact factor: 4.411

6.  UBN2 promotes tumor progression via the Ras/MAPK pathway and predicts poor prognosis in colorectal cancer.

Authors:  Ya-Li Zhao; Shen-Rong Zhong; Shi-Hong Zhang; Jia-Xin Bi; Zhi-Yuan Xiao; Shu-Yang Wang; Hong-Li Jiao; Dan Zhang; Jun-Feng Qiu; Ling-Jie Zhang; Cheng-Mei Huang; Xiao-Ling Chen; Yan-Qing Ding; Ya-Ping Ye; Li Liang; Wen-Ting Liao
Journal:  Cancer Cell Int       Date:  2019-05-10       Impact factor: 5.722

Review 7.  Garlic: a review of potential therapeutic effects.

Authors:  Leyla Bayan; Peir Hossain Koulivand; Ali Gorji
Journal:  Avicenna J Phytomed       Date:  2014-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.